TCL Archive RAS Mutations Can Predict Resistance To Vectibix, FOLFOX Combination Treatment September 27, 2013
TCL Archive Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis November 28, 2014
TCL Archive NCI To Pay 34 Percent Of Grants, At 155 Payline; $100 Million for Centers to Fund All Core Grants January 29, 1988